Among the Cregs analyzed on the surface of lymphocytes, monocytes and granulocytes of healthy donors and CAD patients, significantly lower expression of CD46 and CD55 was observed on all leukocyte subsets in CAD patients suggesting a global downregulation of these two Cregs in CAD patients, irrespective of disease stage. This evidence concerns the gene CD46 and coronary artery disorder.